Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide
Loading...
Official URL
Full text at PDC
Publication date
2020
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SPRINGERNATURE
Citation
Huntley, D., Giménez, E., Pascual, M.J. et al. Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant 55, 1493–1496 (2020). https://doi.org/10.1038/s41409-020-0950-1
Abstract
Cytomegalovirus (CMV) DNAemia remains a clinically relevant problem following allogeneic stem cell transplantation (allo-HSCT). Currently, enumeration of IFN-γ- producing CMV-specific T cells provides helpful yet improvable data for patient stratification for risk of primary or recurrent CMV DNAemia and for predicting clinically refractory episodes of CMV DNAemia.
Description
grant from Carlos III Health Institute (15/0060)